Security key
03770N101
Apogee Therapeutics, Inc. - Common Stock (APGE)
CUSIP: 03770N101
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 41,768,396
- Total 13F value
- $1,163,676,392
- Share change
- +1,655,805
- SEC-reported price per share
- $27.94
- Number of holders
- 85
- Value change
- +$48,111,524
- Number of buys
- 53
- Number of sells
- 18
- Shares outstanding
- 62,702,889
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
85
Top holders
10
APGE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Apogee Therapeutics, Inc. SEC filings
Apogee Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03770N101
Recent filing periods:
Ownership snapshot
Top reported holders of APGE - Apogee Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Venrock Adviser, LLC
Disclosed value leader
Venrock Adviser, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2023
13F
Lead comparable stake: 14%
Showing 1-6 of 15 holder rows.
Quick read
Venrock Adviser, LLC leads the comparable SEC ownership view at 14%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Venrock Adviser, LLC's linked filing trail.
Comparable ownership
Top 5
Venrock Adviser, LLC
14%
FMR LLC
7.1%
Fairmount Funds Management LLC
4.7%
Deep Track Capital, LP
3.9%
RTW INVESTMENTS, LP
3.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Venrock Adviser, LLC |
13F
Company
|
14%
|
$180,907,737
8,493,321 shares
|
— | 30 Sep 2023 |
| FMR LLC |
13F
Company
|
7.1%
|
$89,618,736
4,439,798 shares
|
— | 30 Sep 2023 |
| Fairmount Funds Management LLC |
13F
Company
|
4.7%
|
$62,647,049
2,941,176 shares
|
— | 30 Sep 2023 |
| Deep Track Capital, LP |
13F
Company
|
3.9%
|
$51,426,145
2,414,373 shares
|
— | 30 Sep 2023 |
| RTW INVESTMENTS, LP |
13F
Company
|
3.4%
|
$45,637,188
2,142,591 shares
|
— | 30 Sep 2023 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
3.2%
|
$42,129,291
1,977,901 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
85
Shares
41,768,396
Rows available
85
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
73
Q4 2023 holders
85
Holder diff
12
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend